FDA Chief Asks Congress To Require Device Makers To Report Shortages
Commissioner says pressure on dwindling N95 mask supply for COVID-19 outbreak will ease due to CDC’s regulatory flexibility guidance
Executive Summary
At an 11 March FDA budget hearing, US FDA Commissioner Stephen Hahn renewed his request for legislation to require medtech manufacturers to report to FDA any anticipated or existing shortages of devices.
You may also be interested in...
$8.3Bn Coronavirus Response Act Lays Out US FDA’s, CDC’s And Localities’ Roles In Fighting Virus
An $8.3bn “Coronavirus Preparedness and Response Supplemental” funding act approved by the US Congress last week and signed into law on 6 March provides dollars and lays out the roles federal agencies, such as the FDA, and state and local agencies must play in containing and controlling the spread of COVID-19.
FDA’s Device Center Could Raid $2.8M From Staff Outreach, Training Kitty In 2021 To Fund Other CDRH Needs
While the Trump administration’s proposed fiscal year 2021 budget for the US FDA would give the agency’s device center a 5.3% increase for medtech product approvals and safety, the center’s lofty plans to become the world’s premier regulator of new AI-driven gadgets, next-gen diagnostics and other novel devices means it will have to tap about $2.8m dollars usually set aside for staff training and outreach to help meet its ambitious goals.
CDC Urges Diagnostics Makers To Scale Up Coronavirus Test
The second in command at the US Centers for Disease Control and Prevention said with the help of the Chinese government, the agency was quickly able to develop a diagnostic test for the new coronavirus – but now the private sector should use its resources to scale up production of the tests.